Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05163886
What this trial is testing

Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
OrphAI Therapeutics 14
Not applicableLooking for participantsNCT03233646
What this trial is testing

Retinal Imaging in Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's Disease+12 more
Duke University 2,000
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07703462
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for a Participant With TARDBP ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
n-Lorem Foundation 1
Not applicableLooking for participantsNCT06917924
What this trial is testing

A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
A.O.U. Città della Salute e della Scienza 200
Not applicableLooking for participantsNCT06051123
What this trial is testing

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Who this might be right for
ALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableUnknownNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Early research (Phase 1)Active Not RecruitingNCT05633459
What this trial is testing

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
QurAlis Corporation 69
Not applicableNot Yet RecruitingNCT07706270
What this trial is testing

Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Neurodegenerative DisordersMotor Neuron Diseases
University Hospital, Montpellier 138
Testing effectiveness (Phase 2)WithdrawnNCT01565395
What this trial is testing

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Parkinson DiseaseAmyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center
Not applicableStudy completedNCT06206629
What this trial is testing

Contralateral R1 in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Hospices Civils de Lyon 120
Not applicableLooking for participantsNCT06581861
What this trial is testing

PREVENT ALL ALS Study

Who this might be right for
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix 600
Testing effectiveness (Phase 2)Study completedNCT03828123
What this trial is testing

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Bioinova, s.r.o. 26
Not applicableStudy completedNCT00812851
What this trial is testing

Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
CrampsAmyotrophic Lateral Sclerosis
Cantonal Hospital of St. Gallen 24
Not applicableStudy completedNCT02408900
What this trial is testing

Muscle Ultrasound Measures as Biomarkers of Upper Motor Neuron Function

Who this might be right for
Muscle Spasticity
National Institute of Neurological Disorders and Stroke (NINDS) 15
Not applicableStudy completedNCT02675075
What this trial is testing

DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
VA Office of Research and Development 34
Testing effectiveness (Phase 2)Study completedNCT01709149
What this trial is testing

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 711
Not applicableLooking for participantsNCT04363684
What this trial is testing

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Who this might be right for
Frontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)+11 more
Mayo Clinic 2,100
Testing effectiveness (Phase 2)Study completedNCT01020331
What this trial is testing

Memantine Therapy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Phoenix Neurological Associates, LTD 20
Not applicableUnknownNCT01378026
What this trial is testing

Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation

Who this might be right for
Amyotrophic Lateral SclerosisAlzheimer DiseaseParkinson's Disease
China Medical University Hospital 120
Very early researchLooking for participantsNCT06849609
What this trial is testing

Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Hong Chen 6
Next Page